519P - Folfoxiri + Bevacizumab (Bev) in Patients (Pts) with Previously Untreated Metastatic Colorectal Cancer (Mcrc): Final Survival and Pharmacogenomic Profiling Results from the Opal Study
| Autor: | Stein, A., Atanackovic, D., Stoehlmacher, J., Hildebrandt, B., Stübs, P., Steffens, C., Brugger, W., Hapke, G., Illerhaus, G., Bluemner, E., Bokemeyer, C. |
|---|---|
| Zdroj: | In Annals of Oncology September 2014 25 Supplement 4:iv176-iv176 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|